CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 15 enrolled
Drug / intervention
MED-EL Cochlear Implant Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05250414
NCT05250414N/ACompleted

Cochlear Implantation in the Single-Sided Deafness in the Medicare Population

Med-El Corporation·interventional·Posted Feb 22, 2022·Updated Sep 29, 2025

In Brief

A clinical study evaluating MED-EL Cochlear Implant System for Hearing Loss, Unilateral. Completed, enrolled 15 participants across 3 sites in 2 countries.

Detailed Summary

The purpose of this study is to evaluate the safety and effectiveness of cochlear implantation in adults 65 years of age and older.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesCanada, United States
Collaborators--

Timeline

N/ACompletedFinished
2023202420252026
First PostedFeb 22, 2022
Enrollment StartJun 27, 2022
Primary CompletionAug 11, 2025
TodayJul 2, 2026
Enrollment to primary: 3.1 yearsPosted 4.4 years ago

Interventions

MED-EL Cochlear Implant Systemdevice

Cochlear implant and audio processor